Market Place
Sourcing Support
Genentech`s Biologics Hemlibra Receive Suppl Approval in US
08 Jul 2025 //
FDA
Pfizer`s Biologics Elrexfio Receive Suppl Approval in US
08 Jul 2025 //
FDA
Esjay`s Generics Ketoconazole Receives Approval in US
03 Jul 2025 //
FDA
Regeneron`s Biologics Lynozyfic Receive Approval in US
02 Jul 2025 //
FDA
Eli Lilly`s Biologics Kisunla Receive Suppl Approval in US
01 Jul 2025 //
FDA
BMS`s Biologics Opdivo Receive Suppl Approval in US
01 Jul 2025 //
FDA
Annora Pharma`s Generics Prucalopride Receives Approval in US
24 Jun 2025 //
FDA
Aggrega`s Generics Prucalopride Receives Approval in US
24 Jun 2025 //
FDA
H2-Pharma`s Generics Prucalopride Receives Approval in US
24 Jun 2025 //
FDA
Unique`s Generics Alcohol Receives Approval in US
23 Jun 2025 //
FDA
Unique`s Generics Amitriptyline HCl Receives Approval in US
23 Jun 2025 //
FDA
Torrent`s Generics Apremilast Receives Approval in US
20 Jun 2025 //
FDA
GSK`s Biologics Benlysta Receives Suppl Approval in US
20 Jun 2025 //
FDA
Immunex`s Biologics Enbrel Receives Suppl Approval in US
18 Jun 2025 //
FDA
Cipla`s Generics Abacavir Receives Tentative Approval in US
12 Jun 2025 //
FDA
Nexus`s Generics Minocycline Receives Tentative Approval in US
12 Jun 2025 //
FDA
Xiromed`s Generics Selenious Receives Tentative Approval in US
12 Jun 2025 //
FDA
UBI`s Generics Olanzapine Receives Approval in US
11 Jun 2025 //
FDA
Appco`s Generics Tranexamic Acid Receives Approval in US
11 Jun 2025 //
FDA
Zenara`s Generics Sapropterin Receives Approval in US
11 Jun 2025 //
FDA
Aspiro`s Generics Selenious Acid Receives Approval in US
11 Jun 2025 //
FDA
Zydus Pharma`s Generics Bosentan Receives Approval in US
10 Jun 2025 //
FDA
Lyne`s Generics Polystyrene Sulfonate Receives Approval in US
10 Jun 2025 //
FDA
Stira Pharma`s Generics Zinc Sulfate Receives Approval in US
10 Jun 2025 //
FDA
Azurity`s Xifyrm Receives Approval in US
06 Jun 2025 //
FDA
Samsung Bioepis`s Biologics Opuviz Receives Suppl Approval in US
06 Jun 2025 //
FDA
Astellas`s Biologics Vyloy Receives Suppl Approval in US
06 Jun 2025 //
FDA
Avit`s Generics Sitagliptin Receives Approval in US
02 Jun 2025 //
FDA
Dr Reddy`s Generics Sitagliptin Receives Approval in US
30 May 2025 //
FDA
MSN`s Generics Sacubitril Receives Tentative Approval in US
29 May 2025 //
FDA
Boehringer `s Biologics Spevigo Receives Suppl Approval in US
28 May 2025 //
FDA
BMS`s Biologics Yervoy Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Qvantig Receives Suppl Approval in US
23 May 2025 //
FDA
GSK`s Biologics Nucala Receives Suppl Approval in US
22 May 2025 //
FDA
Merck`s Biologics Keytruda Receives Suppl Approval in US
22 May 2025 //
FDA
Celltrion`s Biologics Herzuma Receives Suppl Approval in US
22 May 2025 //
FDA
Eli Lilly`s Biologics Ebglyss Receives Suppl Approval in US
22 May 2025 //
FDA
Handa Pharma`s Generics Varenicline Receives Approval in US
21 May 2025 //
FDA
Genentech`s Biologics Susvimo Receives Suppl Approval in US
21 May 2025 //
FDA
Mankind Pharma`s Generics Proparacaine Receives Approval in US
21 May 2025 //
FDA
Samsung Bioepis`s Biologics Hadlima Receives Suppl Approval in US
21 May 2025 //
FDA
Sandoz`s Generics Sugammadex Receives Tentative Approval in US
20 May 2025 //
FDA
Amgen`s Biologics Amjevita Receives Suppl Approval in US
20 May 2025 //
FDA
Boehringer`s Biologics Cyltezo Receives Suppl Approval in US
20 May 2025 //
FDA
Galenicum`s Generics Diazepam Receives Approval in US
19 May 2025 //
FDA
Qilu Pharma`s Generics Olanzapine Receives Approval in US
16 May 2025 //
FDA
Incyte`s Biologics Zynyz Receives Suppl Approval in US
15 May 2025 //
FDA
Dr Reddy`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
InvaGen`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Alembic`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Macleod`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Sunshine`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Biocon`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Ascent`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Genentech`s Biologics Piasky Receives Suppl Approval in US
14 May 2025 //
FDA
BMS`s Augtyro Receives Approval in Canada
07 May 2025 //
HEALTH CANADA
Lupin`s Generics Raltegravir Receives Approval in US
07 May 2025 //
FDA
Chemi SpA`s Generics Glatiramer Receives Approval in US
07 May 2025 //
FDA
AbbVie`s Biologics Skyrizi Receives Suppl Approval in US
07 May 2025 //
FDA
